Recent News
Atsena Therapeutics Process Development Opportunity
The Chase Group is pleased to announce their continued partnership with Atsena Therapeutics after being retained to execute a search for an Associate Director/Director of… Continue Reading →
Arcturus Retains The Chase Group to Expand Vaccine Development Programs
As part of its growth strategy, Arcturus Therapeutics has partnered with The Chase Group to build and expand their vaccines development team. Founded in 2013… Continue Reading →Ionis VP Medical Affairs Successfully Placed by The Chase Group
Ionis Pharmaceuticals has a 30-year track record of perfecting and advancing RNA-targeted drug discovery and development and is now expanding its commercialization capabilities. That expansion… Continue Reading →
High Expectations, Inspired By Patients and Fueled By Innovation
With a pipeline of more than 40 medicines, Ionis Pharmaceuticals is using its groundbreaking antisense therapies to bring better health and healing to millions of people. As clinical development and commercialization efforts continue to accelerate, Ionis works with The Chase Group to find leaders and executives who share a passion for helping patients, strive for excellence, and dare to dream big. Continue Reading →The Chase Group Secures SVP, Regulatory for Atsena Therapeutics in Impressive Timeframe
After a comprehensive executive search that was completed in less than six weeks, The Chase Group is pleased to announce the placement of Dr. Molly… Continue Reading →
The Chase Group Retained to Identify Vice President, Manufacturing/Supply Chain
Ventria Bioscience has partnered with The Chase Group to continue building its leadership team. The company’s technology is time-proven, with more than ten years of… Continue Reading →
Delivering Better Cancer Outcomes With the Best Teams
Checkmate Pharmaceuticals, a clinical stage immuno-oncology company, is focused on pioneering new medicines for combating melanoma, non-melanoma skin cancers, and head and neck cancer. Dr. James Wooldridge, Chief Medical Officer, has partnered with The Chase Group on executive search projects because of the thoroughness, productivity, and expert evaluations he receives from Chase as he builds out his clinical development and regulatory affairs teams at this fast-moving startup. Continue Reading →Successful Collaboration Results in VP Finance Placement at Ionis
The Chase Group (TCG) is pleased to announce the successful recruitment of James Haney as the Vice President of Finance at Ionis Pharmaceuticals. Haney joins… Continue Reading →